Investors. Presentations. There are no presentations available at this time. Shareholder Tools. Print Page. Email Alerts · RSS Feeds · Investor Contact.
The Investor Relations website contains information about AN2 Therapeutics, Inc's business for stockholders, potential investors, and financial analysts.
Investor Relations. Company Overview. Avalo (AVTX) is a clinical stage ... Avalo Reports 2023 Financial Results and Provides Business Updates. Mar 27, 2024 • 4 ...
Missing: antx | Show results with:antx
(Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.61. The reported EPS for the same ...
AN2 Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View ANTX financial statements in full.
Missing: relations | Show results with:relations
Find the latest AN2 Therapeutics, Inc. (ANTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Rating
(3,975)
AN2 Therapeutics, Inc. (ANTX) will release its next earnings report on May 8, 2024. In the last quarter AN2 Therapeutics, Inc. reported -$0.736 EPS in ...
People also ask
Who is the CEO of AN2 therapeutics?
What is investor relations in real estate?
Get AN2 Therapeutics Inc (ANTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.